Cigna Group: Form 10-K for the period ended Dec 31, 2024
Filed with the SEC on Feb 27, 2025 and accepted by EDGAR at Feb 27, 2025, 18:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $247.12bn | us-gaap:Revenues |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $182.51bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 12 months2024-01-01 to 2024-12-31 | $14.84bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | $9.42bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-01-01 to 2024-12-31 | $1.49bn | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | $12.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | $12.25 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 283,218,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $10.36bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2024-01-01 to 2024-12-31 | $1.57bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2024-01-01 to 2024-12-31 | $7.03bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-12-31 | $7.55bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $48.87bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $155.88bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $57.98bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $114.64bn | us-gaap:Liabilities |
| Current portion of debt | At period end2024-12-31 | $3.04bn | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2024-12-31 | $880.0m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2024-12-31 | $41.03bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001739940-25-000009. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.